$500 million, $200 million, $100 million ......
Recently, the north of the river, "hot" climb.Eight companies have come out with good news about financing in quick succession.From gene editing drugs to millimeter wave radar, from anti-cancer innovative drugs to semiconductor materials, in different tracks, different stages of the enterprise, are intensive to take the "vote of confidence" of the capital.
"New financing every day."This once somewhat exaggerated statement is becoming little by little a real everyday occurrence in this hot land.

01
By combing these eight financings in sequence, a clear relay of innovation can be seen.
At the end of May, Extreme Molybdenum Core and Yuanmai CellsBe the first to take financingThe company's main focus is on two-dimensional semiconductor materials. Extreme Molybdenum Core focuses on 2D semiconductor materials and completed an angel round of financing, while Yuanmai Cell focuses on CAR-M and was also backed by a Pre-A round this time.
Yao Tang Bio is a close second.proximalA $500 million Series C financingThe company is led by CZG Capital, followed by Shanghai Guotou Pioneer and old shareholders such as Fengqi Yun, which makes a complete lineup. This in vivo gene editing drug company is showing a strong "gold-absorbing power".

Come June, the good news intensified:
On June 1, Imran Bio announced the completion of thePre-A round of financing. This biomaterials intellectual enterprise, plans to focus this round of financing on the technology iteration, production capacity expansion and market channel expansion of new biodegradable chiral new materials, to accelerate the industrialization of the landing.
On June 2, Wickell Pharmaceuticals and Hyunjia Technology announced back-to-back the completion of new rounds of financing. One.Nearly $200 million in Series C3 financing, a Pre-IPO round is moving forward; aFirst stage of Series B financingAll are key enablers in the company's charge to the next stage of growth.
On June 3, Chuhang Technology announcedCompletion of the C round of financing, the amount of financing more than 100 million dollarsAs a "core player" in multi-modal millimeter wave radar, the team will continue to expand the company's leading position in the field of spatial intelligent sensing. As a "core player" in multi-modal millimeter wave radar, the team will continue to expand the company's leading edge in the field of spatial intelligent sensing.
On June 4, Asahi Technology announced the completion of a new round of financing. This young company, founded only 3 years ago, is becoming an innovative force in the field of membrane separation technology ......
From early beginnings to a dash for an IPO, from biopharmaceuticals to hard-core materials, theOne after another, one after another, the innovative energy of the new district, just run out.
02
Eight companies are raising money intensively and reaping capital attention because of theEach of them has a "winning formula".

The largest amount of this financing comes from Yaotang Bio. And this innovative team, which has six pipelines entering the clinical stage, leads the world. The first domestic LNP in vivo gene editing drug based on LNP that has entered the registered clinic is coming from here.
New Small Molecule Targeted Anti-tumor Drugs Independently Developed by Vickers PharmaceuticalsAnritriptanib (VC004) has beenApproved for listingVicagrelor capsules have been selected for four major national scientific and technological projects; Yuanmai Cell's MACF-001 project has completed the first patient enrollment and ended the safety follow-up at the Liver Disease Center of the General Hospital of the Eastern Theater of Operations, and some of the patient's indexes related to cirrhosis of the liver appeared to be significantly improved.

Chuhang Technology's millimeter wave radar has entered the supply chain of Geely, Chery, Great Wall and other 30 car companies, the team is also deeply involved in the development of industry standards; Polar Molybdenum Core's products serve the University of Cambridge, The Chinese University of Hong Kong, Fudan University, and other top domestic and foreign scientific research institutes and industrial institutions, and has reached a cooperation with the downstream chip makers ......
Not only is there a "winning move", and this "move", actually made, run through, by the market verification.The ability is hard enough, naturally win the favor of capital.
03
A wave of "financing fever" is good news for 8 enterprises; looking deeper, we can also see a vibrant industrial ecology.

Take Yuanmai Cell and Molybdenum Core, both are "NU Department" enterprises. Dr. Zhuo Fulin, founder of Molybdenum Core, graduated from Nanjing University, and his brothers and sisters started the business together; Shen Pingping, founder of Yuanmai Cell, is a professor at the School of Life Sciences of Nanjing University, and has been deeply cultivated in the field for more than 20 years.
It is not a coincidence that in the north of the river, there are always universities and colleges in the scientific research results in this root and sprout. Nanda University, Dongda University, Pharmaceutical University and a number of colleges and universities, and the new area closely hand in hand.Professors lead students in entrepreneurial endeavors.son (older than oneself) of one's teacherpullyoung disciple (of the same master)Involvement, in situ transformation of good technology.constituteA constant.
Half of the eight newly financed companies are from Biomedical Valley. In this park, more than 1,300 enterprises are clustered, and they may find upstream and downstream partners and clinical resources just by taking a few steps. The time for a new idea to become a new product is greatly shortened, and enterprises naturally run faster.
A group of enterprises intensively harvested good news, because the north of the river has long had a whole branch of leafy"The Forest of Science and Innovation".this is"New financing every day" is the real reason why Jiangbei has been trading long termism.fig. when conditions are right, success will follow naturallyThe
The story continues.
Looking forward to more good news~

